BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12224371)

  • 1. Anemia in CKD: prevalence, diagnosis, and treatment. Case study of the anemic patient.
    Kammerer J; Ratican M; Elzein H; Mapes D
    Nephrol Nurs J; 2002 Aug; 29(4):371-4. PubMed ID: 12224371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and management of anemia in renal transplantation: an observational-French study].
    Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
    Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of anemia in patients with chronic kidney disease.
    McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
    Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anemia in the nursing home: contribution of chronic kidney disease.
    Robinson B; Artz AS; Culleton B; Critchlow C; Sciarra A; Audhya P
    J Am Geriatr Soc; 2007 Oct; 55(10):1566-70. PubMed ID: 17727646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient.
    Butler KG
    Nephrol Nurs J; 2002 Apr; 29(2):189-92. PubMed ID: 11997954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
    Germain M; Ram CV; Bhaduri S; Tang KL; Klausner M; Curzi M
    Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia management in chronic kidney disease.
    Gillespie BS; Inrig JK; Szczech LA
    Hemodial Int; 2007 Jan; 11(1):15-20. PubMed ID: 17257350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Ritz E; Laville M; Bilous RW; O'Donoghue D; Scherhag A; Burger U; de Alvaro F;
    Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?
    Berns JS
    Semin Dial; 2005; 18(1):22-9. PubMed ID: 15663760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality].
    Nakamura Y; Tsuchiya K; Nitta K; Ando M
    Nihon Jinzo Gakkai Shi; 2011; 53(1):38-45. PubMed ID: 21370576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A; Covic A; Locatelli F; Macdougall IC;
    Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Lacson E; Ofsthun N; Lazarus JM
    Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure.
    Wexler D; Silverberg D; Sheps D; Blum M; Keren G; Iaina A; Schwartz D
    Int J Cardiol; 2004 Jul; 96(1):79-87. PubMed ID: 15203265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The First European Renal Association-European Dialysis and Transplant Association CKD Anaemia Physician Behaviours Survey: key findings.
    Cannata-Andía JB; Locatelli F; Zoccali C
    J Nephrol; 2008; 21(2):190-6. PubMed ID: 18446713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of renal anemia in progression of chronic kidney disease].
    Racki S; Maleta I
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():33-7. PubMed ID: 20235353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the anemia of end-stage renal disease after hospitalization.
    Krishnan M; Adams E
    Nephrol Nurs J; 2004; 31(5):541-4. PubMed ID: 15518256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
    Artunc F; Risler T
    Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.